Topiramate Tablets Topiramate is a medication that treats epilepsy by preventing and managing seizures. This medication can also prevent migraine headaches. Topiramate works by calming overactive nerves in your body. Brand names for this medication are Topamax® and Topiragen®. Overview: Topiramate is used to treat or prevent seizures. It is also used to prevent migraines. It may work by affecting certain signals in the brain. Common side effects include dizziness. Topamax (topiramate) is FDA-approved to treat seizures in adults and children and reduce the frequency of migraine headaches in people 12 years of age and older. While Topamax is effective, it has potentially serious side effects like eye issues, kidney stones and metabolic acidosis (acid buildup). Fact Checked Why Trust Drugwatch? Topiramate, marketed as Topamax among other names, is an oral medication primarily prescribed for the treatment of epilepsy and the prophylaxis of migraines. [8] Learn about Topamax (topiramate), from its FDA-approved uses for migraine and seizures to side effects like weight loss to dosage info and safety tips. Do not double doses. If your next regular dose of Topamax® capsule or tablet or Eprontia® oral solution is within 6 hours away, wait until then to use the medicine and skip the missed dose. If you miss more than 1 dose of this medicine, contact your doctor for instructions about how to restart it. Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine headaches. Learn about side effects, interactions and indications. Learn about side effects, uses, dosage, and more for Topamax (topiramate). It’s a prescription drug for migraine and epilepsy in children and adults. Topamax (generic name: topiramate) is not a controlled substance in the United States, but it is still a prescription‑only medicine with important safety concerns and specific approved uses. It is not known to be addictive or habit‑forming, and it is not an opioid, benzodiazepine, or stimulant drug. Continue reading TOPAMAX is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.